Company Overview
- Website
- imvax.com
- Phone
- (267) 900-4110
- Employees
- 46
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Recent News & Media
Imvax secures $29m to support Phase IIb glioblastoma therapy trial
- Jan 30, 2025
- clinicaltrialsarena.com
Imvax Announces Completion of $29 Million Financing and Confirms Timing for Topline Results of Phase 2b Trial of IGV-001 in Newly Diagnosed Glioblastoma
- Jan 29, 2025
- businesswire.com
Imvax to Present Safety Data on Lead Program, IGV-001, at 2024 SNO Annual Meeting
- Nov 11, 2024
- businesswire.com
Jefferson spinout Imvax raises $35M to advance brain cancer treatment
- May 23, 2024
- bizjournals.com
Imvax Provides Corporate Update
- Sep 6, 2023
- citybiz.co
Imvax Begins Phase II Trial of Unique Autologous, Tumor-Derived Brain Cancer Therapy
- Apr 4, 2023
- precisionmedicineonline.com
Company Leadership
Companies Similar to Imvax
Analyze industry trends and opportunities by examining competitors and companies comparable to Imvax, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |